Download Cv Europeo Italiano

CURRICULUM VITAE
Personal information
Surname(s) / First name(s)
PERALDO NEIA CATERINA
Address
Telephone
Fax
E-mail
Nationality
Date of birth
Gender
[email protected]
Italian
26/02/1983
Female
Work experience
dates•
Name and address of
employer
Type of business or sector
Occupation or position held
• Main activities and
responsibilities
dates•
Name and address of
employer
Type of business or sector
Occupation or position held
• Main activities and
responsibilities
Pagina 1 - Curriculum vitae di
[ PERALDO NEIA Caterina ]
January 2009 - Today
Institute for Cancer Research and Treatment (IRCC), Strada provinciale 142,
km 3,95, 10060, Candiolo, Torino
Fondazione Edo ed Elvo Tempia Valenta, Via Malta 3, 13900, Biella
Cancer Research, Cancer Genomic Lab
Ph.D student in Human Oncology at University of Turin, Italy
Identification of new molecular targets in cholangiocarcinoma; testing efficacy of
new drugs alone or in combination with chemotherapy in this pathology
January 2008 – December 2008
Institute for Cancer Research and Treatment (IRCC), Strada provinciale 142,
km 3,95, 10060, Candiolo, Torino
Fondazione Edo ed Elvo Tempia Valenta, Via Malta 3, 13900, Biella
Cancer Research, Cancer Genomic Lab
Scholarship holder at Fondazione Edo ed Elvo Tempia Valenta
Gene expression profiling, mutational analysis, protein expression of Epidermal
Growth Factor Receptor (EGFR) in prostate cancer patients.
dates•
Name and address of
employer
Type of business or sector
Occupation or position held
• Main activities and
responsibilities
date
• Nome e indirizzo del datore
di lavoro
• Tipo di azienda o settore
• Tipo di impiego
• Principali mansioni e
responsabilità
October 2005 – October 2007
Institute for Cancer Research and Treatment (IRCC), Strada provinciale 142,
km 3,95, 10060, Candiolo, Torino
Fondazione Edo ed Elvo Tempia Valenta, Via Malta 3, 13900, Biella
Cancer Research, Cancer Genomic Lab
Trainee at IRCC-Candiolo and Fondazione Edo ed Elvo Tempia Valenta
DNA and RNA extraction, PCR, mutational analysis, sequences analysis using
Chromas, IHC, gene expression profiling of prostate cander patients by
microarray.
•May 2005 – September 2005
Institute for Cancer Research and Treatment (IRCC), Strada provinciale 142,
km 3,95, 10060, Candiolo, Torino
Cancer Research
Trainee
DNA extraction, PCR, mutational analysis, sequences analysis using Chromas.
Education and training
Dates
Name and type of organisation
providing education and
training
Principal subjects/occupational
skills covered
Title of qualification awarded
Level in national or
international classification
Dates
Name and type of organisation
providing education and
training
Principal subjects/occupational
skills covered
Title of qualification awarded
Pagina 2 - Curriculum vitae di
[ PERALDO NEIA Caterina ]
September 2005 – October 2007
University of Turin, Italy
Molecular Biology, Cellular Biology, Biochemestry, Microbiology
Master degree in Biomolecular Science, with 108/110. Title of thesis:
“Expression and mutations of EGFR and gene expression profilng in prostate
cancer”.
Master degree
September 2002 – September 2005
University of Turin, Italy
Elements of Molecular Biology, Cellular Biology, Biochemestry
Bachelor degree in Biological Science with 96/110. Title of thesis: “Mutational
analysis of epidermal growth factor in cholangiocarcinoma”
Level in national or
international classification
Dates
Name and type of organisation
providing education and
training
Principal subjects/occupational
skills covered
Title of qualification awarded
Level in national or
international classification
Bachelor degree
September 1997- June 2002
Classic Lyceum “Massimo D’Azeglio”, Via Parini, 8 10121, Torino, Italy
Italian, Latin, Classical Greek, History, Philosophy, Science, English, Art,
Physics, Maths
Graduate at Classic Lyceum with 84/100.
Graduation
Personal skills and
competences .
MOTHER TONGUE
ITALIAN
Other language
ENGLISH
• Understanding
• Speaking
• Writing
Social skills and
competences.
Organisational skills and
competences.
Pagina 3 - Curriculum vitae di
[ PERALDO NEIA Caterina ]
Excellent
Very Good
Very good
Ability to work in team.
Good autonomy
Experience in voluntary association, parish summer camps
Technical skills and
competences.
Driving licence
Pagina 4 - Curriculum vitae di
[ PERALDO NEIA Caterina ]

DNA and RNA extraction from fresh tissues, paraffin-embadded tissues,
cell lines, blood

Sequences analysis using “Chromas” software

Immunohistochemistry on paraffin-embadded or Glyofixx embedded
tissues

Immunocytochemistry and Immunofluorescence

Cultures of cancer cell lines

In vitro assay to test antiproliferative effect of drugs, migration and
invasion

Western Blot analysis

Amplification and purification of nucleic acids.

Qualitative and quantitative control of RNA by BioAnalyzer (Agilent)

Labelling and Hybridization of probes for gene expression profiling by
microarray

Validation of microarray data by Real-Time RT-PCR

Animal manipulation

Ability to use principle browsers to obtain data of biological importance

Good skill of Windows and its applications ( word, excel, power point)
Driver licence B
Additional information
December 2007: State exam for biologist profession
Publications:




Peraldo-Neia C, Migliardi G, Mello-Grand M, Montemurro F, Segir R, Pignochino Y,
Cavalloni G, Torchio B, Mosso L, Chiorino G, Aglietta M. Epidermal Growth Factor
Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein
expression in primary prostate cancer. BMC Cancer. 2011 Jan 25;11:31. PubMed
PMID: 21266046.
Valabrega G, Capellero S, Cavalloni G, Zaccarello G, Petrelli A, Migliardi G, Milani A,
Peraldo-Neia C, Gammaitoni L, Sapino A, Pecchioni C, Moggio A, Giordano S,
Aglietta M, Montemurro F. HER2-positive breast cancer cells resistant to trastuzumab
and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase
inhibitor sorafenib. Breast Cancer Res Treat. 2010 Dec 9.[Epub ahead of print]
PubMed PMID: 21153051.
Pignochino Y, Sarotto I, Peraldo-Neia C, Penachioni JY, Cavalloni G, Migliardi G,
Casorzo L, Chiorino G, Risio M, Bardelli A, Aglietta M, Leone F. Targeting
EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary
tract and gallbladder carcinomas. BMC Cancer. 2010 Nov 18;10:631. PubMed PMID:
21087480
Cavalloni G, Peraldo Neia C, Sarotto I, Gammaitoni L, Migliardi G, Soster M
Marchio S, Aglietta M, Leone F. Antitumor activity of Src inhibitor Saracatinib
(AZD-0530) in preclinical models of biliary tract carcinomas. Mol Cancer Ther.
2012 Mar 27. [Epub ahead of print] PubMed PMID: 22452946.
Poster
Pagina 5 - Curriculum vitae di
[ PERALDO NEIA Caterina ]

Caterina Peraldo Neia1,2, Giorgia Migliardi1, Maurizia Mello Grand2, Raffaella Segir2,
Ymera Pignochino1, Giuliana Cavalloni1, Bruno Torchio3, Luciano Mosso3, Giovanna
Chiorino2, Massimo Aglietta1 “Gene profiling, expression and mutations of
Epidermal Growth Factor Receptor (EGFR) in androgen-dependent prostate
cancer”. Abstract accepted at 21st Pezcoller Symposium

Peraldo Neia Caterina, Pignochino Ymera, Cavalloni Giuliana , Sarotto Ivana, Aglietta
Massimo, Leone Francesco “Enhancement of antiproliferative effect of
gemcitabine by EGFR and HER2 pathway inhibition in bile duct carcinomas”.
Abstract accpeted at 51° Congresso Nazionale della Società Italiana di Cancerologia

Giorgio Valabrega1,2, Sonia Capellero2, Giuliana Cavalloni2, Gianluca Zaccarello3 ,
Annalisa Petrelli4, Giorgia Migliardi2, Andrea Milani1, Caterina Peraldo Neia5, Loretta
Gammaitoni2, Francesco Favero5, Aldo Moggio2, Silvia Giordano1,4, Massimo
Aglietta1,2 and Filippo Montemurro2 “HER2-positive breast cancer cells resistant to
trastuzumab and lapatinib lose reliance upon HER2 and become sensitive to the
multitargeted kinase inhibitor sorafenib”. Abstract accepted at 2009 Molecular
Targets and Cancer Therapeutics

Dario Sangiolo, MD, PhD1, Giorgio Valabrega, MD2*, Giuliana Cavalloni, PhD2*, Sonia
Capellero3*, Giulia Mesiano4*, Maja Todorovic1*, Cristina Cammarata5*, Caterina
Peraldo Neia2*, Wanda Piacibello, MD6, Alessandro Cignetti, MD, PhD1* and Massimo
Aglietta, MD4* “MIC A/B Protein Expression Associates with TrastuzumabResistant Breast Cancer Cells Leading to Effective Immunotherapy by Cytokine
Induced Killer Cells”. Abstract accepted at ASH 2009.

Sonia Capellero, Giuliana Cavalloni, Andrea Milani, Caterina Peraldo-Neia, Anna
Sapino, Carla Pecchioni4, Massimo Aglietta, Filippo Montemurro. Overcoming
Trastuzumab resistance in HER2-overexpressing breast cancer cells by
multikinase inhibitor Sorafenib. Accepted at 52nd Annual Meeting of the Italian
Cancer Society Rome.

Caterina Peraldo Neia1, Giovanni Grignani2, Giorgia Migliardi1, Giuliana Cavalloni1,
Alberto Pisacane3, Sandra Aliberti2, Ymera Pignochino, 1 Mauro Risio3, Massimo
Aglietta2 Role of CXCR4/SDF-1 axis in soft tissue sarcoma progression Accepted
at 52nd Annual Meeting of the Italian Cancer Society Rome.
Additional information
Pagina 6 - Curriculum vitae di
[ PERALDO NEIA Caterina ]

Leone Francesco, Peraldo-Neia Caterina, Cavalloni Giuliana, Colombi Federica,
Aglietta Massimo. AZD0530 (saracatinib) inhibits biliary cancer cell motility and
invasion. Accepted at ASCO GI 2011

Peraldo-Neia Caterina, Cavalloni Giuliana, Leone Francesco, Giorgia Migliardi,
Loretta Gammaitoni, Aglietta Massimo. “Anti-tumor activity of Src inhibitor AZD0530 in biliary carcinoma preclinical models”- accepted at 2011 International
Conference “Molecular Clinical Oncology”, Turin.